Market

Coronavirus tally: Global cases of COVID-19 top 217 million as study finds Moderna vaccine produced more antibodies than Pfizer’s

The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to data aggregated by Johns Hopkins University. The U.S. leads the world with a total of 39 million cases and 638,715 deaths. The daily average of new cases over the past seven days rose to 158,946 as of Monday, up 12% from two weeks ago, according to a New York Times tracker. The daily average for deaths increased to 1,348 up 91% in two weeks, and is now trending above 1,000 for the first time since March, the tracker shows. The daily average for hospitalizations rose to 100,663, up 22% from two weeks ago and continuing to trend at the highest levels since winter. A study comparing individual immune responses to two major COVID-19 vaccines has shown that Moderna’s
MRNA,
-3.02%

created more than double the antibodies than that of Pfizer
PFE,
+0.34%

and BioNTech
BNTX,
-3.76%
.
The study involving 2,499 Belgian health-care workers who were vaccinated with two doses of either company’s vaccine was published on Mondayin the Journal of the American Medical Association.
India has the second highest death toll after the U.S. at 438,560 and is third by cases at 32.8 million, the JHU data shows. Brazil has second highest death toll at 579,574 and has 20.8 million cases. In Europe, Russia has 180,009 deaths, followed by the U.K. with 132,808.

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button
Native News Post